• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术治疗宫颈癌卵巢移位复发:系统评价与我们的经验。

Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience.

机构信息

Department of Gynecology, Osaka International Cancer Institute, Osaka 541-8567, Japan.

Department of Forensic Medicine, School of Medicine, Kindai University, Osaka 589-8511, Japan.

出版信息

Curr Oncol. 2022 Sep 29;29(10):7158-7170. doi: 10.3390/curroncol29100563.

DOI:10.3390/curroncol29100563
PMID:36290840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9600108/
Abstract

In early-stage cervical cancer, ovarian metastasis is relatively rare, and ovarian transposition is often performed during surgery. Although rare, the diagnosis and surgical approach for recurrence at transposed ovaries are challenging. This study focused on the diagnosis and surgical management of transposed ovarian recurrence in cervical cancer patients. A 45-year-old premenopausal woman underwent radical hysterectomy, bilateral salpingectomy, and pelvic lymphadenectomy following postoperative concurrent chemoradiotherapy for stage IB1 cervical cancer. During the initial surgery, the ovary was transposed to the paracolic gutter, and no postoperative complications were observed. Ovarian recurrence was diagnosed using positron emission tomography-computed tomography, and a laparoscopic bilateral oophorectomy was performed. A systematic review identified nine women with transposed ovarian recurrence with no other metastases of cervical cancer, and no studies have discussed the optimal surveillance of transposed ovaries. Of those (n = 9), four women had died of the disease within 2 years of the second surgery, and the prognosis of transposed ovarian cervical cancer seemed poor. Nevertheless, three women underwent laparoscopic oophorectomies, none of whom experienced recurrence after the second surgery. Few studies have examined the surgical management of transposed ovarian recurrence. The optimal surgical approach for transposed ovarian recurrence of cervical cancer requires further investigation.

摘要

在早期宫颈癌中,卵巢转移相对较少,手术时通常会进行卵巢移位。尽管罕见,但对于转移卵巢的复发,其诊断和手术方法具有挑战性。本研究专注于宫颈癌患者转移卵巢复发的诊断和手术处理。一名 45 岁的绝经前妇女,在因 IB1 期宫颈癌接受根治性子宫切除术、双侧输卵管切除术和盆腔淋巴结清扫术后,接受了术后同期放化疗。在初始手术中,将卵巢移位到结肠旁沟,未观察到术后并发症。使用正电子发射断层扫描-计算机断层扫描诊断卵巢复发,并进行了腹腔镜双侧卵巢切除术。系统评价确定了 9 名患有转移卵巢复发且无宫颈癌其他转移的妇女,且没有研究讨论过转移卵巢的最佳监测方法。在这些患者中(n=9),有 4 名女性在第二次手术后 2 年内死于疾病,转移卵巢宫颈癌的预后似乎较差。尽管如此,有 3 名女性接受了腹腔镜卵巢切除术,她们在第二次手术后均未复发。很少有研究探讨转移卵巢复发的手术处理。需要进一步研究来确定宫颈癌转移卵巢复发的最佳手术方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d31/9600108/1889dc26741b/curroncol-29-00563-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d31/9600108/0c0b0f01d976/curroncol-29-00563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d31/9600108/4fae87e3cf18/curroncol-29-00563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d31/9600108/8fae9d465077/curroncol-29-00563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d31/9600108/1889dc26741b/curroncol-29-00563-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d31/9600108/0c0b0f01d976/curroncol-29-00563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d31/9600108/4fae87e3cf18/curroncol-29-00563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d31/9600108/8fae9d465077/curroncol-29-00563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d31/9600108/1889dc26741b/curroncol-29-00563-g004.jpg

相似文献

1
Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience.手术治疗宫颈癌卵巢移位复发:系统评价与我们的经验。
Curr Oncol. 2022 Sep 29;29(10):7158-7170. doi: 10.3390/curroncol29100563.
2
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.根治性子宫切除术联合放化疗与单纯根治性子宫切除术治疗局部晚期宫颈癌的疗效比较
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD010260. doi: 10.1002/14651858.CD010260.pub3.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
5
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.超根治性(广泛)手术与标准手术治疗晚期上皮性卵巢癌的初步细胞减灭术。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3.
6
Hormone replacement therapy for women previously treated for endometrial cancer.曾接受子宫内膜癌治疗的女性的激素替代疗法。
Cochrane Database Syst Rev. 2018 May 15;5(5):CD008830. doi: 10.1002/14651858.CD008830.pub3.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.聚(ADP-核糖)聚合酶(PARP)抑制剂治疗卵巢癌。
Cochrane Database Syst Rev. 2022 Feb 16;2(2):CD007929. doi: 10.1002/14651858.CD007929.pub4.
9
Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer.FIGO 分期(2019)IB3/II 期宫颈癌行肿瘤细胞减灭术联合放化疗与单纯放化疗的比较。
Cochrane Database Syst Rev. 2022 Sep 16;9(9):CD012246. doi: 10.1002/14651858.CD012246.pub2.
10
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.对于月经过多进行子宫内膜破坏术前的子宫内膜减薄剂。
Cochrane Database Syst Rev. 2002(3):CD001124. doi: 10.1002/14651858.CD001124.

引用本文的文献

1
Surgical Innovations to Protect Fertility from Oncologic Pelvic Radiation Therapy: Ovarian Transposition and Uterine Fixation.保护生育功能免受盆腔肿瘤放射治疗影响的手术创新:卵巢移位术和子宫固定术。
J Clin Med. 2024 Sep 20;13(18):5577. doi: 10.3390/jcm13185577.

本文引用的文献

1
Outcomes of ovarian transposition in cervical cancer; an updated meta-analysis.卵巢移位术治疗宫颈癌的结局:一项更新的荟萃分析。
BMC Womens Health. 2022 Jul 22;22(1):305. doi: 10.1186/s12905-022-01887-8.
2
Increased mortality and non-cancer morbidity risk may be associated with early menopause and varies with aetiology: An exploratory population-based study using data-linkage.绝经年龄早与死亡率和非癌症发病率升高相关,且与病因相关:基于人群的探索性数据链接研究。
Maturitas. 2022 Oct;164:60-66. doi: 10.1016/j.maturitas.2022.06.011. Epub 2022 Jul 2.
3
Placenta Accreta Spectrum Disorder Complicated with Endometriosis: Systematic Review and Meta-Analysis.
胎盘植入谱系障碍合并子宫内膜异位症:系统评价与Meta分析
Biomedicines. 2022 Feb 6;10(2):390. doi: 10.3390/biomedicines10020390.
4
Placenta Previa Complicated with Endometriosis: Contemporary Clinical Management, Molecular Mechanisms, and Future Research Opportunities.前置胎盘合并子宫内膜异位症:当代临床管理、分子机制及未来研究机遇
Biomedicines. 2021 Oct 26;9(11):1536. doi: 10.3390/biomedicines9111536.
5
Association of Premenopausal Bilateral Oophorectomy With Cognitive Performance and Risk of Mild Cognitive Impairment.绝经前双侧卵巢切除术与认知表现和轻度认知障碍风险的关联。
JAMA Netw Open. 2021 Nov 1;4(11):e2131448. doi: 10.1001/jamanetworkopen.2021.31448.
6
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial.奥拉帕利维持治疗新诊断的 BRCA 突变晚期卵巢癌患者(SOLO1/GOG 3004):一项随机、双盲、安慰剂对照、III 期临床试验的 5 年随访。
Lancet Oncol. 2021 Dec;22(12):1721-1731. doi: 10.1016/S1470-2045(21)00531-3. Epub 2021 Oct 26.
7
Minimally Invasive Surgery and Surgical Volume-Specific Survival and Perioperative Outcome: Unmet Need for Evidence in Gynecologic Malignancy.微创手术与手术量特定的生存率及围手术期结局:妇科恶性肿瘤领域证据的未满足需求
J Clin Med. 2021 Oct 19;10(20):4787. doi: 10.3390/jcm10204787.
8
Cancer of the cervix uteri: 2021 update.子宫颈癌:2021 年更新。
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):28-44. doi: 10.1002/ijgo.13865.
9
Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.卵巢、输卵管及腹膜癌:2021年更新
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):61-85. doi: 10.1002/ijgo.13878.
10
Characteristics of surgically transposed ovaries on F-FDG PET/CT among patients with cancer.癌症患者 F-FDG PET/CT 中手术移位卵巢的特征。
Ann Nucl Med. 2021 Oct;35(10):1100-1108. doi: 10.1007/s12149-021-01645-0. Epub 2021 Jul 26.